Sosum – M
Medical-grade hyaluronic acid filler with LTSR technology offering 12-month durability (CE 284/MDD 93/42/EEC). Contains 24mg/ml cross-linked HA with 98.7% purity index (HPLC verified). Clinically demonstrated 92% patient satisfaction at 6-month follow-up (n=150).
Advanced LTSR Technology & Safety Assurance
Sosum M utilizes patented Low Temperature Stabilization Reaction (LTSR) to create high-density HA matrices with G‧ prime of 450Pa (TA.XT Plus measurements). Dual-phase purification removes 99.99% BDDE residuals (GC-MS verified). Complies with ISO 13485:2016 standards with 0.02% adverse event rate in clinical trials.
Clinical Advantages
Extended Longevity
12-month duration with 85% HA retention at 6 months (MRI volumetric analysis)
Precision Application
Needle force of 0.23N enables smooth tissue integration (3D force transducer data)
Safety Profile
0.5% edema incidence (vs industry average 2.1%) with 29G needle compatibility
Product Specifications
- Composition: Stabilized HA 24mg/ml (±0.5mg)
- Packaging: 1.0ml and 2syringes with 27G/29G needles
- Viscosity: 850 Pa·s (Brookfield DV3T LV)
- pH Level: 7.2-7.6 (USP 791)
- Storage: 2-25°C protected from light
- Shelf Life: 24 months from manufacture
Clinical Protocol
- Needle Selection: 27G for nasolabial folds, 29G for lip contouring
- Injection Depth: Mid-dermal layer (1.5-2.0mm)
- Max Volume: 1.0ml per treatment area
- Touch-up Interval: ≥4 weeks post-treatment
- Sterility: Single-use device
Medical Advisory Notice
Important: Individual results may vary based on tissue characteristics and injection technique. Use only by physicians trained in advanced filler techniques. Contraindicated for patients with active skin infections or hypersensitivity to lidocaine.
Post-treatment monitoring required for 30 minutes post-procedure. Not intended for nasal bridge or periocular areas. Discontinue use immediately if blanching occurs.
Reviews
There are no reviews yet.